PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
18-May-2023 ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT™ - A Shortcut to Successful Lentivirus Manufacturing ProBioGen
18-May-2023 Elevar Therapeutics Submits New Drug Application to FDA for Combination of Rivoceranib and Camrelizumab as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Elevar Therapeutics
18-May-2023 Alliance Pharma and Drug Development Solutions Are Now Resolian Alliance Pharma
17-May-2023 ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT™ - A Shortcut to Successful Lentivirus Manufacturing B3C newswire
17-May-2023 MorphoSys AG Reports Outcome of Annual General Meeting 2023 MorphoSys AG
17-May-2023 STRATEC’S ANNUAL GENERAL MEETING APPROVES FURTHER DIVIDEND INCREASE: DISTRIBUTION RISES TO € 0.97 PER SHARE STRATEC SE
17-May-2023 Evox Therapeutics Granted Key US Exosome Purification Patent to Further Expand Its Leading Patent Portfolio Evox Therapeutics
17-May-2023 Tiziana Life Sciences Announces Chief Medical Officer Invited to Give Presentation on Intranasal Foralumab on May 17 Tiziana Life Sciences
17-May-2023 EDWARDS' AORTIC VALVE WITH RESILIA TISSUE SHOWS FAVORABLE DURABILITY, SAFETY AND EFFICACY OUTCOMES IN SEVEN YEAR DATA Edwards Lifesciences
17-May-2023 The Board of Directors of Moberg Pharma has resolved on record date for the reverse share split Moberg Pharma
17-May-2023 DPG awards Prize to University of Konstanz and TOPTICA The German Physical Society (DPG)
17-May-2023 Coave Therapeutics to Participate in Upcoming Conferences Coave Therapeutics
17-May-2023 BioSenic reacquires global IP rights and provides an update on JTA-004 development BioSenic
17-May-2023 Bulletin from Moberg Pharma’s AGM on May 16th, 2023 Moberg Pharma AB
17-May-2023 Labcorp and Providence Expand Strategic Laboratory Relationship Labcorp
17-May-2023 PAION AG publishes GROUP QUARTERLY STATEMENT for the first quarter of 2023 PAION AG
16-May-2023 Connect in Pharma launches partnerships for global health innovation Connect in Pharma
16-May-2023 HAEMATO AG: Dividend of EUR 1.20 HAEMATO AG
16-May-2023 Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection for the Treatment of T-cell Leukemia Across the United States EVERSANA
16-May-2023 Connect in Pharma launches partnerships for global health innovation Sciad Newswire